MIM
CTIC

MetLife Investment Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

MetLife Investment Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$204K Hold
2022
Q4 		$293K Hold
2022
Q3 		$283K Hold
2022
Q2 		$291K Buy
2018
Q3 		– Sell
2018
Q2 		$137K Buy